Rigorous translational neuroimaging research—spanning biomarker development, longitudinal cohort studies, and advanced analytical frameworks—requires sustained and diversified financial support. The Translational Neuroimaging Laboratory pursues a strategic funding model that combines peer-reviewed competitive grants, institutional resources, philanthropic partnerships, and collaborative agreements to maintain our research infrastructure, support trainees, and advance our mission of enabling preclinical diagnosis of neurodegenerative diseases.
Peer-Reviewed Research Grants
The foundation of our research programme rests on competitive peer-reviewed grants from governmental research agencies and international scientific organizations. These awards fund specific investigator-initiated projects targeting critical questions in Alzheimer's disease biomarkers, tau and amyloid imaging methodologies, and multimodal neuroimaging integration. Peer-reviewed funding provides the intellectual validation and financial resources necessary to conduct rigorous hypothesis-driven research, acquire scanning time at partner imaging facilities, compensate research participants, and support the analytical work required to transform raw imaging data into meaningful scientific insights.
Such grants typically support multi-year projects, enabling the longitudinal studies essential to understanding neurodegenerative progression. Studying disease trajectories over months and years—rather than single time points—requires sustained commitment and funding stability that competitive research awards provide. Our laboratory continuously maintains an active portfolio of peer-reviewed grants addressing complementary aspects of translational neuroimaging.
Institutional and Foundation Support
Academic and hospital foundation funding plays an indispensable role in sustaining our research ecosystem. Institutional support from McGill University, the Research Centre for Studies in Aging, and our affiliated centres provides critical infrastructure funding, core facility access, and seed funding for emerging research directions. Foundation grants often enable exploratory projects, pilot studies, and methodological innovations that generate preliminary data necessary for larger peer-reviewed grant applications.
This type of support frequently covers essential but difficult-to-fund elements of our research programme: maintenance of computing infrastructure, software licensing, technical staff support, and research coordination. Foundation funding also enables us to respond rapidly to emerging scientific opportunities, bridging gaps between major grant cycles and maintaining research momentum during competitive renewal periods.
Philanthropic Contributions
Individual and family philanthropy represents an increasingly important component of our funding model. Philanthropic donors—often motivated by personal experiences with Alzheimer's disease and related dementias—provide flexible funding that accelerates research progress and supports aspects of our work not readily covered by traditional grant mechanisms. Private donations enable us to recruit talented trainees, acquire specialized equipment, attend scientific conferences for knowledge exchange, and pursue innovative research directions that may carry higher scientific risk but potentially transformative impact.
Philanthropic support also sustains our commitment to scientific training and mentorship. Fellowship supplements, travel awards, and research stipends help attract outstanding graduate students, postdoctoral fellows, and clinical research trainees to our laboratory, ensuring the next generation of translational neuroimaging scientists receives rigorous training in this rapidly evolving field.
We welcome inquiries from foundations, families, and individuals interested in supporting Alzheimer's disease research through the Translational Neuroimaging Laboratory. Contributions of all sizes make meaningful differences in our capacity to advance the science of early diagnosis and neurodegeneration biomarkers.
Industry-Academic Collaborations
Strategic partnerships with pharmaceutical companies, biotechnology firms, and medical device manufacturers complement our academic funding base. These collaborations typically focus on biomarker validation, imaging agent evaluation, or analytical method development relevant to drug discovery and clinical trial design. Industry partnerships bring complementary expertise, access to novel compounds or technologies, and perspectives grounded in translational application.
Such collaborations operate under rigorous agreements that preserve academic freedom, ensure timely publication of findings, and maintain our commitment to objective scientific inquiry. Industry funding supports specific collaborative projects while our core research directions remain guided by scientific merit and public health impact rather than commercial considerations.
Trainee Fellowships and Awards
Individual trainee awards—including doctoral scholarships, postdoctoral fellowships, and clinical research awards—constitute another vital funding stream. These competitive awards recognize trainee excellence while providing salary support that enables talented individuals to dedicate focused time to research. Trainee awards reduce pressure on research grants for personnel costs, allowing those funds to support direct research expenses including imaging costs, participant recruitment, and analytical resources.
Our laboratory actively supports trainees in pursuing these competitive awards, providing mentorship in grant writing, research design, and career development. Successfully funded trainees bring not only their stipends but also intellectual energy, fresh perspectives, and external validation of our training environment's quality.
Why Sustained Funding Matters
Translational neuroimaging research demands substantial and sustained investment. Advanced imaging technologies—PET and MRI scanning—carry significant per-session costs. Longitudinal cohort studies require participant retention over years, demanding continuous research coordination, clinical assessment, and participant support. Sophisticated image analysis requires computational infrastructure, specialized software, and expert personnel. Training the next generation of neuroimaging scientists requires stable funding to support multi-year doctoral and postdoctoral programmes.
Our funding model's diversity provides resilience against fluctuations in any single funding source and enables us to maintain the long-term commitments essential to meaningful progress in understanding Alzheimer's disease and neurodegeneration. Sustained support allows us to ask increasingly sophisticated scientific questions, develop and validate novel biomarkers, and contribute to the global effort to enable earlier diagnosis and ultimately disease-modifying interventions.
Partnership Opportunities
We welcome dialogue with foundations, philanthropic organizations, industry partners, and individual donors interested in supporting translational neuroimaging research. Whether your interest lies in supporting specific research projects, trainee development, infrastructure enhancement, or unrestricted programmatic support, we can discuss how your partnership might advance our shared goal of combating Alzheimer's disease and related neurodegenerative conditions through rigorous, innovative science.